About Hospital da Cidade de Passo Fundo; Centro de Pesquisa em Oncologia
"A trajetória do Hospital de Clínicas completou 105 anos no dia 20 de julho de 2019, unificando a experiência no atendimento em saúde e a inovação contínua dos processos e serviços. Com a missão institucional de promover melhorias na qualidade de vida das pessoas, por meio de ações integradas de assistência à saúde, ensino e pesquisa, o Hospital de Clínicas se consolida como referência macrorregional para o atendimento a uma população de mais de cento e quarenta municípios da região Norte do Rio Grande do Sul e Oeste de Santa Catarina."
Clinical Trials at Hospital da Cidade de Passo Fundo; Centro de Pesquisa em Oncologia
During the past decade, Hospital da Cidade de Passo Fundo; Centro de Pesquisa em Oncologia conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 5 clinical trials were completed, i.e. on
average, 166.7% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 3 clinical trials were completed. i.e. 300%
of trials that started reached the finish line.
Clinical Trials Sponsors and Collaborators
Clinical Trials Conditions at Hospital da Cidade de Passo Fundo; Centro de Pesquisa em Oncologia
According to Clinical.Site data, the most researched conditions in "Hospital da Cidade de Passo Fundo; Centro de Pesquisa em Oncologia" are
"Colorectal Cancer" (1 trials), "Lymphocytic Leukemia, Chronic" (1 trials), "Metastatic Breast Cancer" (1 trials), "Non-Hodgkin's Lymphoma" (1 trials) and "Non-Squamous Non-Small Cell Lung Cancer, Squamous Non-Small Cell Lung Cancer" (1 trials). Many other conditions were trialed in "Hospital da Cidade de Passo Fundo; Centro de Pesquisa em Oncologia" in a lesser frequency.
Clinical Trials Intervention Types at Hospital da Cidade de Passo Fundo; Centro de Pesquisa em Oncologia
Most popular intervention types in "Hospital da Cidade de Passo Fundo; Centro de Pesquisa em Oncologia" are "Drug" (6 trials). Other intervention types were less common.
The name of intervention was led by "Atezolizumab" (2 trials), "Carboplatin" (2 trials), "Placebo" (2 trials), "5-FU/LV" (1 trials) and "Atezolizumab (MPDL3280A) [TECENTRIQ], an engineered anti-PDL1 antibody" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Hospital da Cidade de Passo Fundo; Centro de Pesquisa em Oncologia
The vast majority of trials in "Hospital da Cidade de Passo Fundo; Centro de Pesquisa em Oncologia" are
6 trials for "All" genders.
Clinical Trials Status at Hospital da Cidade de Passo Fundo; Centro de Pesquisa em Oncologia
Currently, there are NaN active trials in "Hospital da Cidade de Passo Fundo; Centro de Pesquisa em Oncologia".
undefined are not yet recruiting,
undefined are recruiting,
1 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 5 completed trials in Hospital da Cidade de Passo Fundo; Centro de Pesquisa em Oncologia,
undefined suspended trials,
and undefined terminated clinical trials to date.
Out of the total trials that were conducted in Hospital da Cidade de Passo Fundo; Centro de Pesquisa em Oncologia, 1 "Phase 1"
clinical trials were conducted, 1 "Phase 2" clinical
trials and 4 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".